Mon, August 22, 2016
Fri, August 19, 2016
Thu, August 18, 2016
Wed, August 17, 2016
Tue, August 16, 2016
Mon, August 15, 2016
Fri, August 12, 2016

Matthew Harrison Maintained (BIIB) at Buy with Decreased Target to $368 on, Aug 17th, 2016

Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $385 to $368 on, Aug 17th, 2016.

Matthew has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Aaron Gal of "Bernstein" Initiated at Buy on, Wednesday, June 29th, 2016